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The outcome of cerebral venous thrombosis (CVT) varies
widely, and a poor prognosis is usually associated with
papilloedema, deteriorating consciousness, coma, cerebral
hemorrhage, old age, and delayed diagnosis [1,2]. Internal
jugular vein stenosis may further complicate CVT and
result in the worst outcome. We report a case of CVT
associated with bilateral internal jugular vein stenosis
(BIJVS) that was successfully treated by using a combination
of direct intravenous endovascular thrombolysis and
bilateral internal jugular vein stenting.
CASE PRESENTATION
A 68-year-old male was sent to the emergency room due to
sudden-onset right lower limb weakness associated with
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aggravating non-throbbing headache. His medical history
revealed hypertension, alcohol consumption and smoking.
He was considered to have suffered a minor stroke and was
hospitalized in the neurologic ward. Emergency brain
computed tomography (CT) failed to detect any lesion.
On the second admission day, the right lower limb
weakness rapidly progressed to total right paralysis,
followed by right upper limb focal seizure and delirium
with a Glasgow coma scale (GCS) score of 12 (E3V4M5).
Repeated brain CT revealed a hemorrhagic lesion in the left
parietal lobe (Figure 1A). The patient was immediately
transferred to the neurologic intensive care unit (NICU),
where there was rapid deterioration in consciousness to
stupor (GCS score 7: E1V1M5) and the patient began to
vomit. Contrast-enhanced brain CT revealed enhancement
of the superior sagittal sinus and an empty delta sign
(Figure 1B). Immediate magnetic resonance imaging and
magnetic resonance venography (MRV) disclosed
obstruction of the superior sagittal sinus and right transverse
sinus. Cerebral angiography on the third admission day
showed stenoses in bilateral distal internal jugular veins
(Figure 2A and B) (Table).
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Figure 2. Stenosis in the internal jugular vein: (A) drainage from the external jugular vein (arrow) and (B) stricture in the left internal jugular vein
(large arrowhead) and collateral circulation (small arrowhead). (C) Recovery of blood flow in the right internal jugular vein after stenting (arrow).
Figure 1. (A) Brain computed tomography (CT) shows hemorrhage in the left parietal lobe with perifocal edema. (B) Enhanced brain CT reveals an
empty delta sign (arrow).
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Table. Devices used in cerebral angiography
Left femoral sheath, 7F/9F (Terumo)
Guiding catheter Multipurpose, 7F (with Terumo regular and exchange guidewire)
Microsystems Renegade Hi-Flo + Transcend 0.010" guidewire
Balt COPERNIC balloon catheter = 2
Stenting and percutaneous Terumo Sailor dilatation balloon for PTA: 10 = 40 mm
transarterial angioplasty (PTA) Superstif supporting guidewire: 180 cm
Wallstent: 14 = 60 mm
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Direct intravenous endovascular thrombolysis with
infusion of urokinase 750,000 IU during cerebral
angiography successfully facilitated partial recanalization
of the sinus. On the fourth day of admission, the patient
became more alert (E3V4M6) and headache and vomiting
were greatly relieved. Because BIJVS might cause further
CVT and counteract the effect of direct thrombolytic therapy,
an endovascular procedure was used on the fifth day of
admission for both CVT and BIJVS. Urokinase 250,000 IU
was infused into the superior sagittal sinus, followed by
balloon thrombectomy and deployment of a wallstent
(14 = 60 mm) in the left distal internal jugular vein. The
venous pressure dropped from 26 to 12 mmHg. Thus,
stenting of the right internal jugular vein successfully
restored blood flow (Figure 2C).
Heparin was administered initially to prevent further
venous thrombosis. Treatment was changed to warfarin
several days later. After treatment, the patient regained full
consciousness (E4V5M6), partially recovered his right
muscle power and was free of headache, vomiting and
seizure. An extensive search for the cause of the CVT
revealed nothing specific except the BIJVS, the etiology of
which could not be identified.
DISCUSSION
Clinical symptoms and signs of CVT vary widely, as in our
case who initially presented with only mild right lower
limb weakness, making correct diagnosis difficult. The
premise that brain CTs may be normal in CVT is emphasized
by this case. Thus, MRV should be performed whenever
CVT is suspected.
Treatment of CVT varies according to the clinical condition
of the patient. Heparin was first encouraged over 50 years
ago, and has since proved effective, even in cases associated
with intracerebral hemorrhage [2–4]. Although the types of
heparin and the need for and duration of oral anticoagulation
is still controversial in some cases, heparin has been upheld
as the first-line treatment for CVT. This use was due to
heparin’s safety, feasibility and efficacy [2,4,5], until the
recent introduction of direct endovascular thrombolysis.
Urokinase, streptokinase and recombinant tissue plasminogen
activator (rtPA) are most frequently used in such thrombolytic
therapy. Urokinase was first used to treat CVT in 1971, and the
results were satisfactory in a few small studies [2,4–6]. More
recently, rtPA has been used due to its multiple theoretical
advantages, although there is no evidence that it results in a
better clinical outcome than urokinase or heparin [4,6].
In our case, urokinase was used because it has a similar
effect to rtPA but costs much less, and because it causes
fewer anaphylactic reactions than streptokinase [6].
Experience of combining direct endovascular thrombolysis
and intravenous heparin in the treatment of CVT is limited.
Recanalization of occluded vessels might be faster and
more effective, but there lacks strong evidence that the
clinical outcome is better [4]. Thus, further randomized
trials of heparin injection alone versus direct endovascular
thrombolysis in combination with heparin injection may be
needed. Overall, the role of endovascular thrombolytic
therapy remains controversial and it is generally indicated
for patients who respond poorly to heparin administration,
suffer from a worsening clinical course, or are most severely
affected, due to its potential for hemorrhage [2–5].
CVT associated with internal jugular vein stenosis is a
rare occurrence that has been reported infrequently [7–11].
Internal jugular vein stenosis may be idiopathic or caused
by surgery, central venous catheterization, or trauma, and
may elevate intracranial pressure and cause CVT. Thus,
treatment of such a condition by deployment of a stent in
the internal jugular vein may be beneficial. There have been
a few case reports of successful treatment of bilateral internal
jugular vein occlusions by stent deployment in the internal
jugular veins [9,12].
Due to deteriorating consciousness, old age, increased
intracranial pressure, intracerebral hemorrhage, seizure,
and focal deficits (all of which indicate a poor outcome), we
treated this patient using urokinase instead of heparin in
the initial endovascular thrombolysis. However, the
associated BIJVS had the potential to cause further CVT and
minimize the effect of direct endovascular thrombolysis.
Thus, stents were deployed in bilateral distal jugular veins
to provide better venous outflow, which is helpful in the
recovery of CVT. After stenting, we administered heparin
to prevent further thrombosis. Finally, after the condition of
the patient stabilized, heparin was switched to oral
anticoagulant for further prevention of CVT.
To the best of our knowledge, few reports have
documented successful treatment of CVT associated with
BIJVS. We adopted all current methods in the treatment of
CVT and the result was satisfactory. We conclude that early
stenting may result in better outcome, especially in patients
with rapid or severe neurologic decline. However, venous
stenting is not generally accepted and further randomized
trials may be needed to support this experience. In addition,
BIJVS was likely to have been the cause of CVT and this
raises the possible need for more routine inspection for
jugular stenosis.
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